首页> 外文期刊>Chinese Medical Journal >Posterior chamber phakic intraocular lens implantation for high myopia
【24h】

Posterior chamber phakic intraocular lens implantation for high myopia

机译:后房型人工晶状体植入术治疗高度近视

获取原文
获取原文并翻译 | 示例
           

摘要

Objective To evaluate the efficacy, safety and stability of posterior chamber phakic intraocular lens (PIOLs) implantation for the correction of high myopia. Methods Thirty-nine eyes of twenty patients with high myopia (between - 11.75 and - 25.75 diopters) had a posterior chamber PIOL (Staar ICL) implanted. During 6-48 months' follow-up, visual acuity, refraction, intraocular pressure (IOP), corneal reaction and space between crystal lens and intraocular lens (IOLs) were tested. Results Successful implantation was achieved in all patients. Visual acuity without correction greater than 0.5 was found in 34 eyes at 1 day and 3 months postoperatively. Thirty-five eyes maintained a low negative power of refraction ( -1.42 +- 1.32 doipters), which did not prevent the patients from most of their daily activities. During 3-48 months' follow-up, refraction was stable and no cornea edema and glaucoma was found. Two eyes of one patient had corticosteroid glaucoma and another eye showed cataractogenesis under anterior capsular membrane. Conclusion Posterior chamber PIOL implantation is predictable, safe, and effective in the correction of high myopia, and its indications should be carefully selected.
机译:目的探讨后房角膜人工晶状体植入术治疗高度近视的有效性,安全性和稳定性。方法20例高度近视(屈光度在-11.75和-25.75之间)的患者的39眼植入了后房PIOL(Staar ICL)。在6-48个月的随访期间,测试了视力,屈光度,眼压(IOP),角膜反应以及晶状体和人工晶状体之间的空间(IOL)。结果所有患者均成功植入。术后1天和3个月发现34眼未经矫正的视力大于0.5。三十五只眼睛保持较低的负屈光力(-1.42 +-1.32掺杂物),这并不能阻止患者的大部分日常活动。在3-48个月的随访中,屈光稳定,未见角膜浮肿和青光眼。一名患者的两只眼睛患有皮质类固醇性青光眼,另一只眼睛在前囊膜下显示白内障发生。结论后房PIOL植入治疗高度近视是可预测的,安全的,有效的,应谨慎选择适应症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号